Goal-directed therapy: what we know and what we need to know
View/ Open
Author
O’Neal, Jason B
Shaw, Andrew D
Published Version
https://doi.org/10.1186/s13741-015-0012-1Metadata
Show full item recordCitation
O’Neal, Jason B., and Andrew D Shaw. 2015. “Goal-directed therapy: what we know and what we need to know.” Perioperative Medicine 4 (1): 1. doi:10.1186/s13741-015-0012-1. http://dx.doi.org/10.1186/s13741-015-0012-1.Abstract
Goal-directed therapy (GDT) utilizes monitoring techniques to help guide clinicians with administering fluids, vasopressors, inotropes, or other treatments to patients in various clinical settings. Multiple studies have investigated the potential benefits of GDT, but no consensus on the use of GDT exists. Future trials which address fluid and inotrope choice as well as expanding the results to evaluate patient-centered outcomes in addition to survival are warranted.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328058/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:14065426
Collections
- HMS Scholarly Articles [17921]
Contact administrator regarding this item (to report mistakes or request changes)